During the past decade, Tuberculosis Research Centre conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tuberculosis Research Centre" #1 sponsor was "Tuberculosis Research Centre, India" with 10 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "IUATLD, Inc" with 1 trials sponsored, "Massachusetts General Hospital" with 1 trials sponsored and "Ministry of Science and Technology, India" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tuberculosis Research Centre" #1 collaborator was "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Indian Council of Medical Research" with 2 trials as a collaborator, "All India Institute of Medical Sciences, New Delhi" with 1 trials as a collaborator, "Fenway Community Health" with 1 trials as a collaborator and "Govt. Vellore Medical College and Hospital, Adukkamparai" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Tuberculosis Research Centre" are "Tuberculosis" (4 trials), "Filarial Infection" (2 trials), "Human Immunodeficiency Virus Infections" (2 trials), "COVID" (1 trials) and "COVID-19 Respiratory Infection" (1 trials). Many other conditions were trialed in "Tuberculosis Research Centre" in a lesser frequency.

Most popular intervention types in "Tuberculosis Research Centre" are "Drug" (7 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ethambutol" (2 trials), "Isoniazid" (2 trials), "Moxifloxacin" (2 trials), "Pyrazinamide" (2 trials) and "Anti-TB drugs (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tuberculosis Research Centre" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tuberculosis Research Centre". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Tuberculosis Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tuberculosis Research Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".